Kestra Medical (KMTS) Form 3 — 10,909 RSUs Disclosed by Director

Rhea-AI Filing Summary

Elizabeth Kwo, a director of Kestra Medical Technologies, Ltd. (KMTS), reported ownership of 10,909 restricted stock units (RSUs). The RSUs each convert into one common share and are scheduled to vest on 09/04/2026, subject to her continued service. The Form 3 was filed following an event on 09/03/2025 and is the initial statement disclosing her direct beneficial ownership of these non-derivative securities.

Positive

• Director disclosure provided: The Form 3 transparently reports insider beneficial ownership as required
• Specific holding disclosed: 10,909 restricted stock units detailed with vesting date 09/04/2026

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine initial insider disclosure showing a director holds RSUs that vest in one year.

The Form 3 is a standard initial reporting document that notifies the market of a director's direct beneficial ownership. It specifies 10,909 RSUs that convert one-for-one into common shares and vest on 09/04/2026 contingent on continued service. This disclosure supports transparency around insider holdings but does not by itself indicate any change in control, compensation adjustments, or transactions affecting capital structure.

Securities Analyst

TL;DR: Informational disclosure only; no immediate financial impact on KMTS noted.

The filing documents a non-derivative holding comprised of restricted stock units rather than currently outstanding common shares. Because the RSUs are subject to future vesting, they do not represent immediately transferable shares. For investors, the filing clarifies potential future dilution if and when the RSUs convert, but the document contains no figures on total shares outstanding or material transactions to quantify impact.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kwo Elizabeth

(Last) (First) (Middle)

C/O KESTRA MEDICAL TECHNOLOGIES, LTD.

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND WA 98033

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/03/2025

3. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	10,909(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Elizabeth Kwo	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Elizabeth Kwo report on Form 3 for KMTS?

She reported direct beneficial ownership of 10,909 restricted stock units (RSUs) that each convert to one common share.

When do the reported RSUs vest for KMTS director Elizabeth Kwo?

The RSUs are scheduled to vest on 09/04/2026, subject to the Reporting Person's continued service.

What date triggered the Form 3 filing for KMTS?

The date of the event requiring the statement was 09/03/2025.

Are the reported securities currently common shares or contingent awards?

They are reported as restricted stock units (RSUs), which are contingent awards that will convert into common shares upon vesting.

How did Elizabeth Kwo sign the filing?

The filing shows a signature block signed as /s/ Elizabeth Kwo dated 09/08/2025.